DEUTSCHE BANK AG\ - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 16 filers reported holding KAZIA THERAPEUTICS LTD in Q2 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2021$1,0000.0%890.0%0.00%
Q2 2021$1,0000.0%89
-2.2%
0.00%
Q1 2021$1,0000.0%91
-69.7%
0.00%
Q4 2019$1,0003000.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Atom Investors LP 99,180$857,0000.09%
HighPoint Advisor Group LLC 32,435$368,0000.04%
Transform Wealth, LLC 106,245$95,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 19,600$170,0000.00%
Renaissance Technologies 79,625$688,0000.00%
TRUIST FINANCIAL CORP 35,260$304,0000.00%
UBS Group AG 2,851$25,0000.00%
BREWIN DOLPHIN LTD 32$2760.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 2,800$24,0000.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders